Clinical Development

Phase IIIB-IV research booming

Outsourcing-Pharma: Focus on Phase IIIB-IV research

Phase IIIB-IV research booming

By Kirsty Barnes

Phase IIIB-IV clinical research in the US is now booming, growing
20 per cent annually, compared with only 7 per cent for Phase
II-III research, driven by a surge in public drug safety concerns
and increased drug market competitiveness.

Covance ends 2005 on the upswing

Covance ends 2005 on the upswing

By Kirsty Barnes

Covance closed 2005 on a high after net revenues climbed 16.9 per
cent from 2004 to reach $1.19 bn (€1 bn). The current trend towards
outsourcing R&D, coupled with increased productivity and repeat
business has fuelled the company's...

Follow us

Products

View more

Webinars